WO2016119491A1 - Procédé de préparation de prémélange à multiples antibiotiques - Google Patents
Procédé de préparation de prémélange à multiples antibiotiques Download PDFInfo
- Publication number
- WO2016119491A1 WO2016119491A1 PCT/CN2015/092826 CN2015092826W WO2016119491A1 WO 2016119491 A1 WO2016119491 A1 WO 2016119491A1 CN 2015092826 W CN2015092826 W CN 2015092826W WO 2016119491 A1 WO2016119491 A1 WO 2016119491A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antibiotic
- premix
- preparation
- antibiotics
- acid
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000003242 anti bacterial agent Substances 0.000 title abstract description 12
- 229940088710 antibiotic agent Drugs 0.000 title abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 44
- 230000004151 fermentation Effects 0.000 claims abstract description 44
- 238000001035 drying Methods 0.000 claims abstract description 14
- 239000003381 stabilizer Substances 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 16
- 238000011085 pressure filtration Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 238000007908 dry granulation Methods 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims description 3
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 claims description 3
- 239000010451 perlite Substances 0.000 claims description 3
- 235000019362 perlite Nutrition 0.000 claims description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 229910021536 Zeolite Inorganic materials 0.000 claims description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 2
- 229940113124 polysorbate 60 Drugs 0.000 claims description 2
- 239000010457 zeolite Substances 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims 1
- 239000010903 husk Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 abstract description 2
- 239000012065 filter cake Substances 0.000 abstract 2
- 238000001816 cooling Methods 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 238000007701 flash-distillation Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001358680 Streptomyces aureochromogenes Species 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000853 biopesticidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/12—Powders or granules
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
Definitions
- the invention relates to a preparation method of a multi-antibiotic premix, in particular to a preparation method of a multi-antibiotic premix.
- Polyoxins also known as polyoxomycin, polyoxomycin, and plenum, are broad-spectrum agricultural antibiotics produced by modern bioengineering techniques. Multi-antibiotics have systemic and therapeutic effects and a high degree of target bioselectivity, which can specifically act on common fungal diseases of many crops. The most prominent antibiotics are the strong inhibitory effects on 25 fungal diseases such as flagellum, ascomycetes and semi-bacteria. Studies have shown that gibberellin has a total of 14 components from A to N. Since 1967, ubiquitin has been widely used as an agricultural fungicide for the treatment of rice sheath blight, tomato gray mold and pear black spot. Plant fungal diseases.
- Multi-antibiotics have a good inhibitory effect on the synthesis of chitin in fungal and insect cell walls.
- pluriticmycin has non-target biosafety to vertebrates and mammals.
- it also has a good inhibitory effect on the pathogenic cell Candida albicans causing mucosal and systemic infection.
- the multi-antibiotic has good adaptability and compatibility with nature, and it degrades quickly after application. It has no residue, no pollution, no cross-resistance and strong stability, and has become one of the first-line drugs for domestic bio-pesticide.
- the invention aims at the problem that the stability of the multi-antibiotic product is not strong, and provides a preparation method of the multi-antibiotic premix which is simple and easy, low in cost and obviously improved in stability of the obtained product.
- the technical scheme of the invention is: a preparation method of a multi-antibiotic premix, the specific steps of which are as follows:
- Pretreatment ferment the fermented multi-antibiotic fermentation liquid to 60-70 ° C for 5-10 min, cool, adjust the pH to 2.5-5.0 with acid, add stabilizer and auxiliary;
- step (1) the multi-antibiotic fermentation broth pretreated in step (1) is subjected to plate and frame press filtration to obtain a multi-antibiotic wet cake;
- step (3) flash drying pulverization: the wet cake obtained in step (2) is flash-dried, the inlet air temperature is controlled to 110-130 ° C, the outlet temperature is 60-70 ° C, the material temperature is 80-100 ° C, and after drying. Obtaining a multi-antibiotic mycelium dry product;
- premix According to the purity of the multi-antibiotic mycelium dry product and the content of the finished product, the powder carrier is added and uniformly mixed to obtain a powdery multi-antibiotic premix;
- Granulation The powdery multi-antibiotic premix obtained in the step (4) is subjected to dry granulation and sieved to obtain a granulated multi-antibiotic premix.
- the fermented titer of the fermented multi-antibiotic fermentation broth described in the step (1) is from 2000 to 2500 ⁇ g/mL.
- the medium and culture conditions for fermentation were disclosed in "A Streptomyces and Multi-antibiotic Metabolic Regulation Fermentation Process" (ZL201210056364.2) submitted by the research group.
- the fermentation broth of the fermentation broth was 2000-2500 ⁇ g/mL.
- the strain used in the fermentation is the self-screening Streptomyces aureochromogenes NJYHWG66382CGMCC No. 5756, which has been patented as ZL201210056364.2, and the invention title is "a Streptomyces and multi-antibiotic metabolism regulation process" invention patent
- the deposit was carried out in the middle of the general microbiology center of the China Microbial Culture Collection Management Committee. The deposit date was February 14, 2012. The patent was published on August 22, 2012, and the CGMCC No. 5756 strain was used. The species has been made public.
- the pressure of the plate frame press filtration described in the step (2) is 1.0 to 5.0 MPa, and the pressure filtration time is 1 to 2 hours.
- the multi-antibiotic wet cake described in the step (2) has a water content of 30 to 40%.
- the powder carrier in the step (4) is any one of rice hull powder, calcium carbonate, perlite and zeolite powder; the powder carrier has a particle size of 80 to 100 mesh; and the powder carrier is added in powder form.
- the multi-antibiotic premix has a mass of 55% to 81%.
- step (5) is subjected to dry granulation and passed through a sieve of 20 to 100 mesh.
- the invention pretreats the fermentation broth of the multi-antibiotic, thereby changing the quality of the multi-antibiotic premix product, so that the degradation degree of the multi-antibiotic is significantly reduced, and the stability of the multi-antibiotic premix product is greatly improved.
- the invention adopts the new process of preparing multi-antibiotic premix by plate frame filtration, flash drying, granulation, etc., the granulation rate and the yield of the multi-antibiotic premix are greatly improved, the cost is lowered, and the product is better. Adapt to market demand.
- the obtained multi-antibiotic premix has improved stability of titer, which makes it more convenient and stable in transportation, storage and application.
- the fermentation broth used is a fermentation broth obtained by fermentation of Streptomyces aureochromogenes NJYHWG66382CGMCC No. 5756. After the fermentation is completed, the stirring and temperature control are stopped, and the fermentation broth has a titer of 2000 to 2500 ⁇ g. /mL.
- the medium and culture conditions for the specific fermentation were carried out in accordance with "a Streptomyces and Multi-antibiotic Metabolic Regulation Fermentation Process" (ZL201210056364.2) submitted by the research group.
- Pretreatment Take 1000L fermentation broth of fermented multi-antibiotic fermentation liquid (fermentation titer is 2140 ⁇ g/mL) Heat to 60 ° C, maintain for 5 min, cool, adjust the pH to 2.5 with hydrochloric acid, add 1.5% copper sulfate as the stabilizer, and the fermentation liquid quality 0.2% Toween 80 as an auxiliary.
- step (2) Pressure filtration: the multi-antibiotic fermentation broth pretreated in step (1) is subjected to plate and frame pressure filtration, the pressure of the pressure filtration is controlled to 1.0 MPa, and the filtration time is 2 hours, and a multi-antibiotic wet cake having a water content of 30% is obtained. 174kg.
- Premix preparation 215.3 kg of rice hull powder was added to the dried product obtained in the step (3), and uniformly mixed to obtain 267.5 kg of a powdery multi-antibiotic premix having a multi-antibiotic content of 0.8%.
- Granulation The powdery multi-antibiotic premix obtained in the step (4) is subjected to dry granulation, and finally passed through a 60-mesh sieve to obtain a multi-antibiotic premix granule having a particle size of 60 mesh.
- the granulation rate and yield of the 0.8% multi-antibiotic premix prepared by the test were improved by about 15% and the stability was improved by about 9%.
- Pretreatment Take 1000L of fermented multi-antibiotic fermentation broth (fermentation titer of 2340 ⁇ g/mL) and heat to 65°C for 7min, cool, adjust the pH to 3.0 with phosphoric acid, and add 2.0% of the fermentation broth quality.
- Aluminum sulfate was used as a stabilizer, and the fermentation liquid quality was 0.25%, and the Span 60 was used as an auxiliary agent.
- step (1) the multi-antibiotic fermentation liquid pretreated in step (1) is subjected to plate and frame pressure filtration to control the pressure of the pressure filtration to be 2.0 MPa, and the filtration time is 1.5 hours to obtain a wet cake of water content of 34% more antibiotics. 156kg.
- Premix preparation 104 kg of calcium carbonate was added to the dried product obtained in the step (3), and the mixture was uniformly mixed to obtain 156 kg of a powdery multi-antibiotic premix having a mass content of 1.5%.
- Granulation The powdery multi-antibiotic premix obtained in the step (4) is subjected to dry granulation, and finally passed through an 80-mesh sieve to obtain a multi-antibiotic premix granule having a particle size of 80 mesh.
- the granulation rate and yield of the 1.5% multi-antibiotic premix prepared by the test are higher than those obtained by the conventional method. It is about 10% higher and the stability is increased by about 15%.
- Pretreatment Take 1000L of fermented multi-antibiotic fermentation broth (fermentation titer of 2250 ⁇ g/mL) and heat to 70°C for 10min, cool, adjust pH to 4.0 with citric acid, and add 3.0% of fermentation broth quality.
- Aluminum chloride was used as a stabilizer, and the fermentation liquid had a mass of 0.3% polysorbate 60 as an auxiliary.
- step (1) the multi-antibiotic fermentation liquid pretreated in step (1) is subjected to plate and frame pressure filtration to control the pressure of the pressure filtration to be 4.5 MPa, and the pressure filtration time is 2 hours, and the moisture content of the antibacterial wet cake of 40% is obtained. .
- Granulation The powdery multi-antibiotic premix obtained in the step (4) is subjected to dry granulation, and finally passed through a 100 mesh sieve to obtain a multi-antibiotic premix granule having a particle size of 100 mesh.
- the 2.0% multi-antibiotic premix prepared by the test has an increase in granulation rate and yield of about 20% and a stability improvement of about 10%.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Toxicology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
La présente invention concerne un procédé de préparation de prémélange à multiples antibiotiques, comprenant les étapes suivantes : chauffer une liqueur de fermentation à multiples antibiotiques fermentés jusqu'à 60-70 °C, et maintenir pendant 5-10 minutes ; refroidir, ajuster le pH à 2,5-5,0 grâce à un acide, ajouter un agent stabilisant et un agent auxiliaire, bien mélanger, et effectuer une filtration à plateaux et cadres de la liqueur fermentée pour obtenir un gâteau de filtration humide à multiples antibiotiques ; puis effectuer une distillation éclair du gâteau de filtration et sécher, broyer, ajouter du matériau auxiliaire et diluer pour obtenir le prémélange à multiples antibiotiques. La présente invention est simple et facile à exploiter et de faible coût ; la stabilité du produit fini prémélange à multiples antibiotiques obtenu est visiblement améliorée pendant le processus de stockage, de façon que le prémélange à multiples antibiotiques soit plus pratique et plus stable pendant les processus de stockage, de transport et d'application.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510044283.4A CN104621156B (zh) | 2015-01-28 | 2015-01-28 | 一种多抗霉素预混剂的制备方法 |
CN2015100442834 | 2015-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016119491A1 true WO2016119491A1 (fr) | 2016-08-04 |
Family
ID=53200808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2015/092826 WO2016119491A1 (fr) | 2015-01-28 | 2015-10-26 | Procédé de préparation de prémélange à multiples antibiotiques |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN104621156B (fr) |
WO (1) | WO2016119491A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104621156B (zh) * | 2015-01-28 | 2017-04-05 | 南京工业大学 | 一种多抗霉素预混剂的制备方法 |
CN110483617A (zh) * | 2019-09-17 | 2019-11-22 | 陕西绿盾环境工程研究院有限公司 | 一种高含量多抗霉素原粉的制备方法 |
CN110592159B (zh) * | 2019-09-23 | 2021-04-09 | 浙江拜克生物科技有限公司 | 一种莫能菌素预混剂的制备工艺及装置 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102424636A (zh) * | 2011-09-27 | 2012-04-25 | 陕西绿盾生物制品有限责任公司 | 多抗霉素残渣生产有机肥的方法 |
CN102885056A (zh) * | 2011-07-22 | 2013-01-23 | 湖北绿天地生物科技有限公司 | 一种纳他霉素制剂及其制备方法 |
CN103145489A (zh) * | 2013-02-20 | 2013-06-12 | 游彩霞 | 一种多抗霉素可湿性粉剂及其制备方法 |
CN103230582A (zh) * | 2013-04-17 | 2013-08-07 | 南京工业大学 | 一种持久霉素预混剂的制备方法 |
CN104621156A (zh) * | 2015-01-28 | 2015-05-20 | 南京工业大学 | 一种多抗菌素预混剂的制备方法 |
-
2015
- 2015-01-28 CN CN201510044283.4A patent/CN104621156B/zh active Active
- 2015-10-26 WO PCT/CN2015/092826 patent/WO2016119491A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102885056A (zh) * | 2011-07-22 | 2013-01-23 | 湖北绿天地生物科技有限公司 | 一种纳他霉素制剂及其制备方法 |
CN102424636A (zh) * | 2011-09-27 | 2012-04-25 | 陕西绿盾生物制品有限责任公司 | 多抗霉素残渣生产有机肥的方法 |
CN103145489A (zh) * | 2013-02-20 | 2013-06-12 | 游彩霞 | 一种多抗霉素可湿性粉剂及其制备方法 |
CN103230582A (zh) * | 2013-04-17 | 2013-08-07 | 南京工业大学 | 一种持久霉素预混剂的制备方法 |
CN104621156A (zh) * | 2015-01-28 | 2015-05-20 | 南京工业大学 | 一种多抗菌素预混剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104621156B (zh) | 2017-04-05 |
CN104621156A (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109504719B (zh) | 一种提高谷氨酸产酸率及提取率的方法 | |
CN102633865B (zh) | 一种恩拉霉素发酵液的预处理方法及以其制备恩拉霉素预混剂的方法 | |
CN104757273B (zh) | 一种制备颗粒型苏氨酸产品的工艺 | |
WO2016119491A1 (fr) | Procédé de préparation de prémélange à multiples antibiotiques | |
CN107828702B (zh) | 一种春雷霉素发酵培养基及发酵方法 | |
EP3239300A1 (fr) | Procédé de préparation de stallimycine | |
CN113061061A (zh) | 一种富含γ-氨基丁酸的化学肥料制备方法 | |
CN110684675A (zh) | 一种三孢布拉氏霉菌发酵方法及其产品 | |
CN106478762A (zh) | 一种甘草酸二铵盐的制备方法 | |
CN113293110B (zh) | 一种抗菌脂肽类化合物的制备方法 | |
CN103789359B (zh) | 一种利用小麦麸皮水解糖发酵产苹果酸的方法 | |
CN111139273B (zh) | 一种制备、分离和提取l-色氨酸的方法 | |
CN110668977B (zh) | 一种月桂酰精氨酸乙酯盐酸盐的制备工艺 | |
CN109321626B (zh) | 一种提高金霉素产量的培养基和生产金霉素的方法 | |
CN114848599B (zh) | 一种高稳定性金霉素预混剂及其制备方法 | |
CN106432037B (zh) | 一种n-溴代丁二酰亚胺的无污染制备方法 | |
CN111808788B (zh) | 一种屎肠球菌菌粉及其制备方法和应用 | |
CN111011388B (zh) | 一种二甲基黄青霉素在抗植物致病真菌中的应用 | |
CN106701864B (zh) | 一种提高井冈霉素产量的方法 | |
CN109608523B (zh) | 一种高纯度替考拉宁的生产工艺 | |
WO2023001893A4 (fr) | Sel d'ulodésine | |
CN102633862B (zh) | 农用尼可霉素原药制备方法 | |
CN107353163A (zh) | 一种农用保水剂及其制备方法 | |
CN104276967A (zh) | 一种生产低含量赖氨酸产品的方法 | |
CN104672190B (zh) | 一种赤霉素母液再结晶的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15879689 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15879689 Country of ref document: EP Kind code of ref document: A1 |